Hanson Kristopher: insider trades.
Hanson Kristopher reported 9 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($801K), across 1 company.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 8
- Companies
- 1
- Name as filed
- Hanson Kristopher
Companies
| Company | Relationship | Transactions |
|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | Officer · General Counsel | 9 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | MapLight Therapeutics, Inc. | S | 16,509 | $11.67 | 137,044 | Form 4 |
| 2026-08-17 | MapLight Therapeutics, Inc. | A | 7,730 | $0 | 153,553 | Form 4 |
| 2026-07-17 | MapLight Therapeutics, Inc. | S | 1,130 | $37.9 | 145,823 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 3,331 | $37.26 | 146,964 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 4,776 | $36.45 | 150,295 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 11 | $37.96 | 146,953 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 5,103 | $36.99 | 155,081 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 2,147 | $36 | 160,184 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 10 | $37.54 | 155,071 | Form 4 |
Questions
What stock did Hanson Kristopher buy or sell?
Hanson Kristopher reported 9 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($801K), across 1 company.
Is Hanson Kristopher the same person as other filers with this name?
This page covers SEC CIK 1789970 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hanson-kristopher-1789970.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.